Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.
Mansfield AS, Peikert T, Smadbeck JB, Udell JBM, Garcia-Rivera E, Elsbernd L, Erskine CL, Van Keulen VP, Kosari F, Murphy SJ, Ren H, Serla VV, Schaefer Klein JL, Karagouga G, Harris FR, Sosa C, Johnson SH, Nevala W, Markovic SN, Bungum AO, Edell ES, Dong H, Cheville JC, Aubry MC, Jen J, Vasmatzis G. Mansfield AS, et al. Among authors: erskine cl. J Thorac Oncol. 2019 Feb;14(2):276-287. doi: 10.1016/j.jtho.2018.10.001. Epub 2018 Oct 10. J Thorac Oncol. 2019. PMID: 30316012 Free PMC article.
Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis.
Pennington K, Sasieta HC, Ramos GP, Erskine CL, Van Keulen VP, Peikert T, Escalante P. Pennington K, et al. Among authors: erskine cl. Clin Med Insights Case Rep. 2017 Aug 24;10:1179547617724776. doi: 10.1177/1179547617724776. eCollection 2017. Clin Med Insights Case Rep. 2017. PMID: 28890660 Free PMC article.
Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy.
Marty PK, Van Keulen VP, Erskine CL, Shah M, Hummel A, Stachowitz M, Fatis S, Granger D, Block MS, Duarte-García A, Warrington KJ, Theel ES, Zhou X, Zeng H, Specks U, Escalante P, Peikert T. Marty PK, et al. Among authors: erskine cl. Front Immunol. 2022 Jan 28;13:834981. doi: 10.3389/fimmu.2022.834981. eCollection 2022. Front Immunol. 2022. PMID: 35154159 Free PMC article.
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2.
Mudrick HE, Massey S, McGlinch EB, Parrett BJ, Hemsath JR, Barry ME, Rubin JD, Uzendu C, Hansen MJ, Erskine CL, Van Keulen VP, Drelich A, Panos JA, Fida M, Suh GA, Peikert T, Block MS, Tseng CK, Olivier GR, Barry MA. Mudrick HE, et al. Among authors: erskine cl. Sci Adv. 2022 Aug 26;8(34):eabm8563. doi: 10.1126/sciadv.abm8563. Epub 2022 Aug 24. Sci Adv. 2022. PMID: 36001674 Free PMC article.
Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 Infection.
Marty PK, Pathakumari B, Shah M, Keulen VP, Erskine CL, Block MS, Arias-Sanchez P, Escalante P, Peikert T. Marty PK, et al. Among authors: erskine cl. Res Sq [Preprint]. 2023 Aug 24:rs.3.rs-3222112. doi: 10.21203/rs.3.rs-3222112/v1. Res Sq. 2023. PMID: 37674707 Free PMC article. Updated. Preprint.
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
Hieken TJ, Nelson GD, Flotte TJ, Grewal EP, Chen J, McWilliams RR, Kottschade LA, Yang L, Domingo-Musibay E, Dronca RS, Yan Y, Markovic SN, Dimou A, Montane HN, Erskine CL, Piltin MA, Price DL, Khariwala SS, Hui J, Strand CA, Harrington SM, Suman VJ, Dong H, Block MS. Hieken TJ, et al. Among authors: erskine cl. Nat Commun. 2024 Feb 16;15(1):1430. doi: 10.1038/s41467-024-45798-8. Nat Commun. 2024. PMID: 38365756 Free PMC article. Clinical Trial.
33 results